Morpholino and Phosphorothioate Antisense Oligomers Compared in Cell-Free and In-Cell Systems
- 1 April 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antisense and Nucleic Acid Drug Development
- Vol. 7 (2) , 63-70
- https://doi.org/10.1089/oli.1.1997.7.63
Abstract
Morpholino and phosphorothioate (S-DNA) antisense oligos were compared in both cell-free and in-cell translation systems. In the most stringent test of specificity in the cell-free system, a globin-targeted S-DNA oligo was found to inhibit its target sequence at concentrations of 10 nM and above, but the sequence-specific component of this inhibition dropped below 50% at concentrations of 100 nM and above. A corresponding Morpholino oligo achieved even higher inhibition at 10 nM, but in contrast to the S-DNA, with the Morpholino, the sequence-specific component of this inhibition remained above 93% at a concentration of 3000 nM. In this same cell-free test system, several S-DNA oligos exhibited substantial undesired nonantisense effects at concentrations of 300 nM and above, whereas corresponding Morpholino oligos exhibited little or no nonantisense activity through a concentration of 3000 nM. In scrape-loaded HeLa cells, both globin-targeted and HBV-targeted S-DNAs (both antisense and control oligos) generally failed to achieve significant translational inhibition at extracellular concentrations up to 3000 nM. In contrast, the Morpholino oligos achieved effective and specific translational inhibition at extracellular concentrations ranging from 30 nM to 3000 nM.Keywords
This publication has 15 references indexed in Scilit:
- Resistance of Morpholino Phosphorodiamidate Oligomers to Enzymatic DegradationAntisense and Nucleic Acid Drug Development, 1996
- Does antisense exist?Nature Medicine, 1995
- Site and Mechanism of Antisense Inhibition by C-5 Propyne OligonucleotidesBiochemistry, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides.Proceedings of the National Academy of Sciences, 1994
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Intracellular inactivation of specific nucleotide sequences: A general approach to the treatment of viral diseases and virally-mediated cancersJournal of Theoretical Biology, 1979
- Sequence-specific crosslinking agents for nucleic acidsJournal of Molecular Biology, 1978
- Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.Proceedings of the National Academy of Sciences, 1978
- Synthesis of ribonucleosides and diribonucleoside phosphates containing 2-chloro-ethylamine and nitrogen mustard residues.Tetrahedron Letters, 1967